Thelansis’s "Head and Neck Cancer (HNC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Head and Neck Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Head and neck cancer affects nearly 65,000 individuals annually in the United States. Excluding skin and thyroid cancers, over 90% of head and neck malignancies are squamous cell carcinomas (SCCs); the remainder predominantly consists of adenocarcinomas, sarcomas, and lymphomas. A significant majority, exceeding 85%, of patients with head and neck cancer have a history of alcohol consumption, tobacco use, or both. Chronic heavy use of tobacco and alcohol increases the risk of developing squamous cell carcinoma by approximately 40-fold. Other potential risk factors include the use of smokeless tobacco, exposure to sunlight, prior radiation therapy of the head and neck, certain viral infections, poorly fitting dental appliances, chronic candidiasis, and inadequate oral hygiene. In India, the high prevalence of oral cancer is attributed to the chewing of betel quid (paan). For squamous cell carcinoma of the lower lip, prolonged sunlight exposure and tobacco use are the primary etiological factors.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.
1. Key Findings and Analyst Commentary
2. Disease Context
3. Epidemiology
4. Market Size and Forecast
5. Competitive Landscape
6. Unmet Need and TPP Analysis
7. Regulatory and Reimbursement Environments (by country and payer insights)
8. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Head and Neck Cancer (HNC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034 report
Our team will get in touch with you shortly about the Head and Neck Cancer (HNC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034 report.